Chapter/Section Purchase

1 Pet NSAIDs Market Overview
1.1 Product Overview and Scope of Pet NSAIDs
1.2 Pet NSAIDs Segment by Type
1.2.1 Global Pet NSAIDs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Carprofen
1.2.3 Deracoxib
1.2.4 Firocoxib
1.2.5 Meloxicam
1.3 Pet NSAIDs Segment by Application
1.3.1 Global Pet NSAIDs Sales Comparison by Application: (2022-2028)
1.3.2 Dog
1.3.3 Cat
1.3.4 Horse
1.3.5 Others
1.4 Global Pet NSAIDs Market Size Estimates and Forecasts
1.4.1 Global Pet NSAIDs Revenue 2017-2028
1.4.2 Global Pet NSAIDs Sales 2017-2028
1.4.3 Pet NSAIDs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Pet NSAIDs Market Competition by Manufacturers
2.1 Global Pet NSAIDs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Pet NSAIDs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Pet NSAIDs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Pet NSAIDs Manufacturing Sites, Area Served, Product Type
2.5 Pet NSAIDs Market Competitive Situation and Trends
2.5.1 Pet NSAIDs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pet NSAIDs Players Market Share by Revenue
2.5.3 Global Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet NSAIDs Retrospective Market Scenario by Region
3.1 Global Pet NSAIDs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Pet NSAIDs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Pet NSAIDs Market Facts & Figures by Country
3.3.1 North America Pet NSAIDs Sales by Country
3.3.2 North America Pet NSAIDs Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Pet NSAIDs Market Facts & Figures by Country
3.4.1 Europe Pet NSAIDs Sales by Country
3.4.2 Europe Pet NSAIDs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pet NSAIDs Market Facts & Figures by Region
3.5.1 Asia Pacific Pet NSAIDs Sales by Region
3.5.2 Asia Pacific Pet NSAIDs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pet NSAIDs Market Facts & Figures by Country
3.6.1 Latin America Pet NSAIDs Sales by Country
3.6.2 Latin America Pet NSAIDs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pet NSAIDs Market Facts & Figures by Country
3.7.1 Middle East and Africa Pet NSAIDs Sales by Country
3.7.2 Middle East and Africa Pet NSAIDs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pet NSAIDs Historic Market Analysis by Type
4.1 Global Pet NSAIDs Sales Market Share by Type (2017-2022)
4.2 Global Pet NSAIDs Revenue Market Share by Type (2017-2022)
4.3 Global Pet NSAIDs Price by Type (2017-2022)
5 Global Pet NSAIDs Historic Market Analysis by Application
5.1 Global Pet NSAIDs Sales Market Share by Application (2017-2022)
5.2 Global Pet NSAIDs Revenue Market Share by Application (2017-2022)
5.3 Global Pet NSAIDs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Zoetis Pet NSAIDs Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Corporation Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Elanco Pet NSAIDs Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 PREVICOX
6.3.1 PREVICOX Corporation Information
6.3.2 PREVICOX Description and Business Overview
6.3.3 PREVICOX Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 PREVICOX Pet NSAIDs Product Portfolio
6.3.5 PREVICOX Recent Developments/Updates
6.4 Metacam
6.4.1 Metacam Corporation Information
6.4.2 Metacam Description and Business Overview
6.4.3 Metacam Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Metacam Pet NSAIDs Product Portfolio
6.4.5 Metacam Recent Developments/Updates
6.5 Chanelle Pharma
6.5.1 Chanelle Pharma Corporation Information
6.5.2 Chanelle Pharma Description and Business Overview
6.5.3 Chanelle Pharma Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Chanelle Pharma Pet NSAIDs Product Portfolio
6.5.5 Chanelle Pharma Recent Developments/Updates
6.6 AVENTIX
6.6.1 AVENTIX Corporation Information
6.6.2 AVENTIX Description and Business Overview
6.6.3 AVENTIX Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 AVENTIX Pet NSAIDs Product Portfolio
6.6.5 AVENTIX Recent Developments/Updates
6.7 Woodruff
6.6.1 Woodruff Corporation Information
6.6.2 Woodruff Description and Business Overview
6.6.3 Woodruff Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Woodruff Pet NSAIDs Product Portfolio
6.7.5 Woodruff Recent Developments/Updates
6.8 KRKA UK Ltd
6.8.1 KRKA UK Ltd Corporation Information
6.8.2 KRKA UK Ltd Description and Business Overview
6.8.3 KRKA UK Ltd Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 KRKA UK Ltd Pet NSAIDs Product Portfolio
6.8.5 KRKA UK Ltd Recent Developments/Updates
6.9 Dechra
6.9.1 Dechra Corporation Information
6.9.2 Dechra Description and Business Overview
6.9.3 Dechra Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Dechra Pet NSAIDs Product Portfolio
6.9.5 Dechra Recent Developments/Updates
6.10 Parnell
6.10.1 Parnell Corporation Information
6.10.2 Parnell Description and Business Overview
6.10.3 Parnell Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Parnell Pet NSAIDs Product Portfolio
6.10.5 Parnell Recent Developments/Updates
6.11 VetUK
6.11.1 VetUK Corporation Information
6.11.2 VetUK Pet NSAIDs Description and Business Overview
6.11.3 VetUK Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 VetUK Pet NSAIDs Product Portfolio
6.11.5 VetUK Recent Developments/Updates
6.12 Norbrook
6.12.1 Norbrook Corporation Information
6.12.2 Norbrook Pet NSAIDs Description and Business Overview
6.12.3 Norbrook Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Norbrook Pet NSAIDs Product Portfolio
6.12.5 Norbrook Recent Developments/Updates
6.13 Alivira Animal Health
6.13.1 Alivira Animal Health Corporation Information
6.13.2 Alivira Animal Health Pet NSAIDs Description and Business Overview
6.13.3 Alivira Animal Health Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Alivira Animal Health Pet NSAIDs Product Portfolio
6.13.5 Alivira Animal Health Recent Developments/Updates
6.14 Vedco Inc
6.14.1 Vedco Inc Corporation Information
6.14.2 Vedco Inc Pet NSAIDs Description and Business Overview
6.14.3 Vedco Inc Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Vedco Inc Pet NSAIDs Product Portfolio
6.14.5 Vedco Inc Recent Developments/Updates
6.15 Vethical
6.15.1 Vethical Corporation Information
6.15.2 Vethical Pet NSAIDs Description and Business Overview
6.15.3 Vethical Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Vethical Pet NSAIDs Product Portfolio
6.15.5 Vethical Recent Developments/Updates
6.16 Vetoquinol
6.16.1 Vetoquinol Corporation Information
6.16.2 Vetoquinol Pet NSAIDs Description and Business Overview
6.16.3 Vetoquinol Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Vetoquinol Pet NSAIDs Product Portfolio
6.16.5 Vetoquinol Recent Developments/Updates
6.17 Pivetal
6.17.1 Pivetal Corporation Information
6.17.2 Pivetal Pet NSAIDs Description and Business Overview
6.17.3 Pivetal Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Pivetal Pet NSAIDs Product Portfolio
6.17.5 Pivetal Recent Developments/Updates
7 Pet NSAIDs Manufacturing Cost Analysis
7.1 Pet NSAIDs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pet NSAIDs
7.4 Pet NSAIDs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pet NSAIDs Distributors List
8.3 Pet NSAIDs Customers
9 Pet NSAIDs Market Dynamics
9.1 Pet NSAIDs Industry Trends
9.2 Pet NSAIDs Market Drivers
9.3 Pet NSAIDs Market Challenges
9.4 Pet NSAIDs Market Restraints
10 Global Market Forecast
10.1 Pet NSAIDs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pet NSAIDs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Pet NSAIDs by Type (2023-2028)
10.2 Pet NSAIDs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pet NSAIDs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Pet NSAIDs by Application (2023-2028)
10.3 Pet NSAIDs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pet NSAIDs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Pet NSAIDs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer